Rivera Amanda, Barrios Dulce M, Herbach Emma, Kahn Jenna M, Williams Vonetta M, Mehta Keyur J, Wolfson Aaron, Portelance Lorraine, Kamrava Mitchell
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
Stony Brook University Hospital, Stony Brook, New York.
Int J Radiat Oncol Biol Phys. 2025 Jan 1;121(1):118-127. doi: 10.1016/j.ijrobp.2024.07.2150. Epub 2024 Jul 26.
The purpose of this study was to determine the current U.S. practice patterns of analgesia (AG) and anesthesia (AS) for gynecologic brachytherapy (BT) procedures.
A 27-item survey created with expertise from 5 brachytherapists was distributed electronically to 90 U.S. radiation oncology academic programs and publicized on social media and at 2 national meetings from June to October 2023.
Forty-one responses were received (46%). Fifty-four percent identified as female, 66% as Caucasian, and 85% as non-Hispanic/Latino ethnicity. Forty-nine percent use a BT suite ± computed tomography (CT) simulator alone, 39% the operating room ± BT suite or CT simulator or other location, 10% CT simulation room alone, and 2% clinic examination room. Thirty-four percent use general anesthesia alone (GA) for intracavitary BT (n = 41), 20% conscious sedation (CS) alone, 10% oral analgesia (OA) alone, 9% spinal or epidural AS alone, and 27% combination. Among those performing hybrid BT (n = 25), 40% use GA alone, 16% use CS alone, 12% epidural or spinal AS alone, 4% OA alone, and 28% combination. For template interstitial BT (n = 25), 44% use GA alone, 48% epidural alone or in combination with other AS, and 8% CS alone. Twenty-two percent of respondents provide AG or AS during applicator placement only, whereas 32% provide it during placement, planning, treatment, and removal. The most common reasons for not using CS or GA were the lack of AS resources and clinician preference. Seventy-three percent reported the belief that patients suffer from post-traumatic stress disorder symptoms after BT. However, 68% reported not using techniques to alleviate BT-related emotional distress.
Many U.S. brachytherapists report using GA, CS, or epidural AS; however, 10% are using only OA, and 22% offer AG/AS only during applicator placement. Furthermore, a majority of respondents believe post-traumatic stress disorder symptoms can occur after BT, but few offer any intervention. AS resources and clinician preferences should be targeted for the expansion of higher-quality care.
本研究的目的是确定美国目前妇科近距离放射治疗(BT)程序中镇痛(AG)和麻醉(AS)的实践模式。
一项由5名近距离放射治疗专家共同编制的包含27个条目的调查问卷通过电子方式分发给90个美国放射肿瘤学学术项目,并于2023年6月至10月在社交媒体和2次全国会议上进行宣传。
共收到41份回复(回复率46%)。54%的受访者为女性,66%为白种人,85%为非西班牙裔/拉丁裔。49%的人仅使用BT套房±计算机断层扫描(CT)模拟器,39%的人使用手术室±BT套房或CT模拟器或其他地点,10%的人仅使用CT模拟室,2%的人使用诊所检查室。34%的人在腔内BT(n = 41)时仅使用全身麻醉(GA),20%的人仅使用清醒镇静(CS),10%的人仅使用口服镇痛(OA),9%的人仅使用脊髓或硬膜外麻醉(AS),27%的人使用联合麻醉。在进行混合BT的人员中(n = 25),40%的人仅使用GA,16%的人仅使用CS,12%的人仅使用硬膜外或脊髓麻醉,4%的人仅使用OA,28%的人使用联合麻醉。对于模板间质BT(n = 25),44%的人仅使用GA,48%的人仅使用硬膜外麻醉或与其他麻醉联合使用,8%的人仅使用CS。22%的受访者仅在施源器放置期间提供AG或AS,而32%的受访者在放置、计划、治疗和移除期间提供。不使用CS或GA的最常见原因是缺乏麻醉资源和临床医生的偏好。73%的人报告认为患者在BT后患有创伤后应激障碍症状。然而,68%的人报告未使用减轻BT相关情绪困扰的技术。
许多美国近距离放射治疗师报告使用GA、CS或硬膜外麻醉;然而,10%的人仅使用OA,22%的人仅在施源器放置期间提供AG/AS。此外,大多数受访者认为BT后可能出现创伤后应激障碍症状,但很少有人提供任何干预措施。应针对麻醉资源和临床医生的偏好,以扩大高质量护理。